These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 7907024)
21. Pramipexole, a dopamine D2 autoreceptor agonist, decreases the extracellular concentration of dopamine in vivo. Carter AJ; Müller RE Eur J Pharmacol; 1991 Jul; 200(1):65-72. PubMed ID: 1685123 [TBL] [Abstract][Full Text] [Related]
22. In vivo comparisons of the effects of quinpirole and the putative presynaptic dopaminergic agonists B-HT 920 and SND 919 on striatal dopamine and acetylcholine release. Robertson GS; Tham CS; Wilson C; Jakubovic A; Fibiger HC J Pharmacol Exp Ther; 1993 Mar; 264(3):1344-51. PubMed ID: 8095550 [TBL] [Abstract][Full Text] [Related]
23. Dopamine D2 autoreceptors in rats are behaviorally functional at 21 but not 10 days of age. Lin MY; Walters DE Psychopharmacology (Berl); 1994 Mar; 114(2):262-8. PubMed ID: 7838918 [TBL] [Abstract][Full Text] [Related]
25. Interactions between D1 and D2 dopamine receptor family agonists and antagonists: the effects of chronic exposure on behavior and receptor binding in rats and their clinical implications. Braun AR; Laruelle M; Mouradian MM J Neural Transm (Vienna); 1997; 104(4-5):341-62. PubMed ID: 9295170 [TBL] [Abstract][Full Text] [Related]
26. The D2 autoreceptor agonists SND 919 and PD 128483 decrease stereotypy in developing rats. Lin MY; Walters DE Life Sci; 1994; 54(1):PL17-22. PubMed ID: 7902951 [TBL] [Abstract][Full Text] [Related]
27. Anxiogenic-like effects of yohimbine and idazoxan in two behavioral situations in mice. Venault P; Jacquot F; Save E; Sara S; Chapouthier G Life Sci; 1993; 52(7):639-45. PubMed ID: 8094225 [TBL] [Abstract][Full Text] [Related]
28. Effects of alpha-2 adrenoceptor agonists and antagonists on circling behavior in rats with unilateral 6-hydroxydopamine lesions of the nigrostriatal pathway. Chopin P; Colpaert FC; Marien M J Pharmacol Exp Ther; 1999 Feb; 288(2):798-804. PubMed ID: 9918591 [TBL] [Abstract][Full Text] [Related]
29. Antagonism of alpha-adrenoceptor agonist-induced antinociception in the rat. Hayes AG; Skingle M; Tyers MB Neuropharmacology; 1986 Apr; 25(4):397-402. PubMed ID: 2872610 [TBL] [Abstract][Full Text] [Related]
30. The role of dopaminergic receptors in the behavioral effects induced by lisuride in male rats. Baggio G; Ferrari F Psychopharmacology (Berl); 1983; 80(1):38-42. PubMed ID: 6408668 [TBL] [Abstract][Full Text] [Related]
31. Combined alpha2 and D2/3 receptor blockade enhances cortical glutamatergic transmission and reverses cognitive impairment in the rat. Marcus MM; Jardemark KE; Wadenberg ML; Langlois X; Hertel P; Svensson TH Int J Neuropsychopharmacol; 2005 Sep; 8(3):315-27. PubMed ID: 15857571 [TBL] [Abstract][Full Text] [Related]
32. Alpha 1- and alpha 2-adrenoreceptor antagonists differentially influence locomotor and stereotyped behaviour induced by d-amphetamine and apomorphine in the rat. Dickinson SL; Gadie B; Tulloch IF Psychopharmacology (Berl); 1988; 96(4):521-7. PubMed ID: 2907662 [TBL] [Abstract][Full Text] [Related]
33. Biochemical and pharmacological studies on pramipexole, a potent and selective dopamine D2 receptor agonist. Mierau J; Schingnitz G Eur J Pharmacol; 1992 May; 215(2-3):161-70. PubMed ID: 1356788 [TBL] [Abstract][Full Text] [Related]
34. Locomotor inhibition, yawning and vacuous chewing induced by a novel dopamine D2 post-synaptic receptor agonist. Smith HP; Nichols DE; Mailman RB; Lawler CP Eur J Pharmacol; 1997 Mar; 323(1):27-36. PubMed ID: 9105873 [TBL] [Abstract][Full Text] [Related]
35. In vitro and in vivo characterization of the dopamine D4 receptor, serotonin 5-HT2A receptor and alpha-1 adrenoceptor antagonist (R)-(+)-2-amino-4-(4-fluorophenyl)-5-[1-[4-(4-fluorophenyl)-4-oxobutyl] pyrrolidin-3-yl]thiazole (NRA0045). Okuyama S; Chaki S; Yoshikawa R; Suzuki Y; Ogawa S; Imagawa Y; Kawashima N; Ikeda Y; Kumagai T; Nakazato A; Nagamine M; Tomisawa K J Pharmacol Exp Ther; 1997 Jul; 282(1):56-63. PubMed ID: 9223539 [TBL] [Abstract][Full Text] [Related]
36. The dopamine autoreceptor agonist, B-HT 920, preferentially reduces brain dopamine release in vivo: biochemical indices of brain dopamine, noradrenaline and serotonin in ventriculocisternal perfusates in the cat. Pifl C; Pichler L; Kobinger W; Hornykiewicz O Eur J Pharmacol; 1988 Aug; 153(1):33-44. PubMed ID: 2463928 [TBL] [Abstract][Full Text] [Related]
37. Antagonism of drug-induced yawning and penile erections in rats. Gower AJ; Berendsen HH; Broekkamp CL Eur J Pharmacol; 1986 Mar; 122(2):239-44. PubMed ID: 2872065 [TBL] [Abstract][Full Text] [Related]
38. B-HT 958 lowers blood pressure and heart rate in the rat through stimulation of dopamine receptors. Brown MJ; Harland D Br J Pharmacol; 1986 Feb; 87(2):361-70. PubMed ID: 3006858 [TBL] [Abstract][Full Text] [Related]
39. In vivo dopamine agonist properties of rotigotine: Role of D1 and D2 receptors. Fenu S; Espa E; Pisanu A; Di Chiara G Eur J Pharmacol; 2016 Oct; 788():183-191. PubMed ID: 27343381 [TBL] [Abstract][Full Text] [Related]
40. No direct correlation between behaviorally active doses of the dopamine D2 agonist LY 171555 and displacement of [123I]IBZM as measured with SPECT in MPTP monkeys. Vermeulen RJ; Drukarch B; Verhoeff NP; Goosen C; Sahadat MC; Wolters EC; van Royen EA; Stoof JC Synapse; 1994 Jun; 17(2):115-24. PubMed ID: 7916490 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]